Lexaria Bioscience Corp. (LEXX)
0.6514
-0.01
(-1.27%)
USD |
NASDAQ |
Feb 20, 16:00
0.6434
-0.01
(-1.23%)
After-Hours: 20:00
Lexaria Bioscience Market Cap : 16.21M for Feb. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Oncolytics Biotech, Inc. | 103.73M |
| Aurinia Pharmaceuticals, Inc. | 1.899B |
| Edesa Biotech, Inc. | 6.667M |
| Xenon Pharmaceuticals, Inc. | 3.263B |
| ProMIS Neurosciences, Inc. | 34.63M |
Market Cap Related Metrics
| PS Ratio | 23.94 |
| PEG Ratio | -0.0652 |
| Price to Book Value | 3.300 |
| Price | 0.6514 |
| Earnings Yield | -88.18% |
| PEGY Ratio | -0.0652 |